Table 5. Absolute values of PRCCs between parameters related to the control measures and outcome variables for Profile B corresponding to a long-lasting pandemic (R_B = 1.8).

	Total number of cases	Total duration	Mean time to peak	Standard error of time to peak	Number of cities affected
Efficacy
Pandemic vaccination*	0.01	0.02	0.01	0.00	0.01
Masks	0.04	0.06	0.05	0.03	0.02
Antiviral Prophylaxis#	0.01/0.01	0.03/0.04	0.04/0.03	0.05/0.03	0.01/0.02
Antiviral Therapy	0.02	0.05	0.02	0.04	0.03
Isolation	0.04	0.07	0.02	0.06	0.01
Coverage in the target population
Pandemic vaccination*	0.07	0.16	0.09	0.07	0.06
Masks	0.09	0.10	0.09	0.07	0.07
Antiviral Prophylaxis	0.06	0.09	0.06	0.03	0.07
Antiviral Therapy	0.06	0.12	0.08	0.11	0.06
Isolation	0.07	0.14	0.10	0.09	0.04
Pre-pandemic vaccination§	0.48	0.16	0.01	0.31	0.43
Proportion of air travel restrictions	0.03	0.06	0.06	0.05	0.09
Date of introduction
Pandemic vaccination	0.28	0.42	0.32	0.25	0.23
Masks	0.21	0.19	0.23	0.16	0.19
Antiviral Prophylaxis	0.30	0.44	0.34	0.29	0.24
Antiviral Therapy	0.29	0.31	0.30	0.23	0.26
Isolation	0.19	0.26	0.22	0.14	0.15
Travel restrictions	0.03	0.04	0.08	0.04	0.14
Duration of the vaccination campaign	0.05	0.07	0.09	0.08	0.06

^§Vaccine composition based on the pre-pandemic strain.

^*Vaccine composition updated for matching pandemic circulating strains.

^#The first value corresponds to the efficacy for susceptibility to infection and the second one to the efficacy for illness given infection.